Gelnique FDA Approval History
FDA Approved: Yes (First approved January 27, 2009)
Brand name: Gelnique
Generic name: oxybutynin hydrochloride
Dosage form: Topical Gel
Previous Name: OTG
Company: Watson Pharmaceuticals, Inc.
Treatment for: Overactive Bladder
Gelnique (oxybutynin chloride) Gel is a transdermal antispasmodic which is applied to the skin once daily for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and frequency.
Development Timeline for Gelnique
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.